Related Experiment Video
Updated: Jun 1, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Thyroid status and kidney transplantation outcomes.
1Department of Nephrology, Dialysis and Transplantation, Annunziata Hospital, Cosenza, Italy.
Low serum FT3 levels in renal transplant patients correlate with poorer graft function, anemia, and other clinical factors. These findings suggest FT3 may predict kidney transplant outcomes within five years post-transplant.
Area of Science:
- Nephrology
- Endocrinology
- Transplant Surgery
Background:
- End-stage renal disease (ESRD) patients often exhibit thyroid dysfunction.
- The relationship between thyroid function and renal transplant graft outcomes requires further clarification.
Purpose of the Study:
- To assess thyroid function in renal transplant recipients.
- To correlate thyroid hormone levels with graft function and clinical parameters.
Main Methods:
- Cross-sectional study of 136 renal transplant recipients.
- Evaluation of serum FT3, FT4, and TSH levels.
- Correlation analysis with BMI, eGFR, creatinine, proteinuria, electrolytes, lipids, and Hb.
Main Results:
- No significant correlation found between FT4/TSH and clinical variables.
- FT3 levels showed significant differences between sexes.
- FT3 correlated significantly with serum creatinine, eGFR, serum sodium, BMI, and Hb.
Conclusions:
- Low serum FT3 levels are associated with worse graft function, anemia, and altered BMI and sodium levels.
- Serum FT3 may serve as a predictive marker for kidney transplant graft function, particularly in the early post-transplant period (within 5 years).
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations

